Committee on Violence Intervention and Prevention - June 15, 2020

10/11/2020

Attendees Adaugo Amobi, MD, MPH, Chair, presiding Elaine J. Alpert, MD, MPH Christopher E. Barsotti, MD Ylisabyth S. Bradshaw, DO, MS Fiona Danaher, MD Ms. Symren Dhaliwal Barbara Herbert, MD Ms. Margaret Igne Harriet (Robbins) Kantrowitz, RN Mr. Christopher Millman Deepika Sundararaj, MD Staff

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Violence-Intervention-and-Prevention---June-15,-2020/

Committee on Geriatric Medicine - March 18, 2020

10/11/2020

Members Asif Merchant, MD, FACP, CMD, CPE, Chair, presiding Janet Jankowiak, MD Eric Reines, MD, FACP Dana Tripp Beth Warner, DO, CMD Chelsea Wong, MD Ms. Mariette Young Guests Stephanie Baker, MS, Senior Program Coordinator, Healthcentric Advisors Rosanna Bertrand, PhD, Division of Health and E

/Governance-and-Leadership/Committees,-Task-Forces-and-Sections/Committee-on-Geriatric-Medicine---March-18,-2020/

Physician Community Statement on House Energy and Commerce Committee and Senate HELP Committee Surprise Medical Bills Proposal

10/9/2020

/Advocacy/Federal-Advocacy/MMS-Advocacy-Statements/Physician-Community-Statement-on-House-Energy-and-Commerce-Committee-and-Senate-HELP-Committee-Surprise-Medical-Bills-Proposal/

Annual Report

10/9/2020

2020 Annual Report

/Templates/Microsites/Form.aspx?id=4294985923

MMS and Alliance Charitable Foundation 2020 Annual Report (pdf)

10/9/2020

/Charitable_Foundation/MMS_and_Alliance_Charitable_Foundation_2020_Annual_Report_(pdf)/

HHS Top Telemedicine Resources

10/8/2020

/workarea/DownloadAsset.aspx?id=4294985914

Letter to FDA Commissioner Hahn regarding REMS classification for mifepristone

10/7/2020

/Advocacy/Federal-Advocacy/Federal-Advocacy-Letters/Letter-to-FDA-Commissioner-Hahn-regarding-REMS-classification-for-mifepristone/

Letter to FDA Commissioner Hahn regarding REMS classification for mifepristone (PDF)

10/7/2020

/Advocacy/Federal-Advocacy/Federal-Advocacy-Letters/Letter-to-FDA-Commissioner-Hahn-regarding-REMS-classification-for-mifepristone-(PDF)/

Massachusetts Medical Society Comments on CY 2021 Physician Fee Schedule

10/6/2020

/Advocacy/Federal-Advocacy/Federal-Regulatory-Comments/Massachusetts-Medical-Society-Comments-on-CY-2021-Physician-Fee-Schedule/

Delegates' Resources

10/6/2020

/Governance-and-Leadership/House-of-Delegates/Delegates--Resources/